β-Amyloid (Aβ) plaque formation is the major pathological hallmark of Alzheimer’s disease (AD) and constitutes a potentially critical, early inducer driving AD pathogenesis as it precedes other pathological events and cognitive symptoms by decades. It is therefore critical to understand how Aβ pathology is initiated and where and when distinct Aβ species aggregate. Here, we used metabolic isotope labeling in APPNL-G-F knock-in mice together with mass spectrometry imaging to monitor the earliest seeds of Aβ deposition through ongoing plaque development. This allowed visualizing Aβ aggregation dynamics within single plaques across different brain regions. We show that formation of structurally distinct plaques is associated with differential ...
Abstract Amyloid β (Aβ) deposition in the brain is an early and invariable feature of Alzheimer’s di...
The pathological mechanisms underlying Alzheimer's disease (AD) are still not understood. The diseas...
While the molecular mechanisms underlying Alzheimer's disease (AD) remain largely unknown, abnormal ...
beta-Amyloid (A beta) plaque formation is the major pathological hallmark of Alzheimer's disease (AD...
One of the major hallmarks of Alzheimer's disease (AD) pathology is the formation of extracellular a...
Alzheimer’s disease (AD) is a neurodegenerative disorder with clinical manifestations of progressive...
Alzheimer’s disease (AD) is a neurodegenerative disorder with clinical manifestations of progressive...
Alzheimer’s disease (AD) is the most common form of dementia. AD has been linked to the aggregation ...
Senile plaques formed by aggregated amyloid β peptides are one of the major pathological hallmarks o...
Senile plaques formed by aggregated amyloid β peptides are one of the major pathological hallmarks o...
The pathological mechanisms underlying Alzheimer\u27s disease (AD) are still not understood. The dis...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
Abstract Amyloid β (Aβ) deposition in the brain is an early and invariable feature of Alzheimer’s di...
The pathological mechanisms underlying Alzheimer's disease (AD) are still not understood. The diseas...
While the molecular mechanisms underlying Alzheimer's disease (AD) remain largely unknown, abnormal ...
beta-Amyloid (A beta) plaque formation is the major pathological hallmark of Alzheimer's disease (AD...
One of the major hallmarks of Alzheimer's disease (AD) pathology is the formation of extracellular a...
Alzheimer’s disease (AD) is a neurodegenerative disorder with clinical manifestations of progressive...
Alzheimer’s disease (AD) is a neurodegenerative disorder with clinical manifestations of progressive...
Alzheimer’s disease (AD) is the most common form of dementia. AD has been linked to the aggregation ...
Senile plaques formed by aggregated amyloid β peptides are one of the major pathological hallmarks o...
Senile plaques formed by aggregated amyloid β peptides are one of the major pathological hallmarks o...
The pathological mechanisms underlying Alzheimer\u27s disease (AD) are still not understood. The dis...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
A major neuropathological hallmark of Alzheimer's disease is the deposition of amyloid plaques in th...
Abstract Amyloid β (Aβ) deposition in the brain is an early and invariable feature of Alzheimer’s di...
The pathological mechanisms underlying Alzheimer's disease (AD) are still not understood. The diseas...
While the molecular mechanisms underlying Alzheimer's disease (AD) remain largely unknown, abnormal ...